MDCT findings after hepatic chemoembolization with DC-beads: what the radiologist needs to know
| Autor: | Mariana Cecilia Kucharczyk, Ricardo Garcia-Monaco, Hernan Irusta, Ezequiel Levy Yeyati, Juan Carlos Spina, Jesica Lorena Savluk, Marina Ulla |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Urology medicine.medical_treatment Antineoplastic Agents Recurrent Tumor Necrosis Internal medicine Edema Parenchyma Multidetector Computed Tomography medicine Humans Radiology Nuclear Medicine and imaging Embolization Chemoembolization Therapeutic Transcatheter arterial chemoembolization Radiological and Ultrasound Technology Bile duct business.industry Therapeutic effect Liver Neoplasms Gastroenterology General Medicine Hepatology Microspheres Radiographic Image Enhancement medicine.anatomical_structure Radiology Bile Ducts medicine.symptom business Tomography X-Ray Computed Dilatation Pathologic |
| Zdroj: | Abdominal imaging. 38(4) |
| ISSN: | 1432-0509 |
| Popis: | Transcatheter arterial chemoembolization with drug-eluting beads (TACE-DC-beads) is a new local treatment for primary or metastatic liver tumors. Despite technical efforts to achieve highly selective embolization of the tumor-supplying vessels, small, or large insults to the non-tumorous parenchyma are inevitably induced by the embolic materials or procedure itself. Parenchymal changes following TACE-DC-beads include bile duct injuries (bile duct dilatation, periportal edema, and bilomas), obliteration of intrahepatic portal vein branches, hypodense ill-defined areas, and perilesional parenchymal enhancement. The radiologist must be familiar with the changes induced by this treatment in order to distinguish therapeutic effect and collateral findings from complications and residual or recurrent tumor. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink